Co-op, Gene Therapy Immunogenicity

in January 2025. The Gene Therapy Accelerator Unit (GTxAU)'s remit is to develop safe and efficacious gene therapies for patients... therapy attributes, their performance in vivo (biodistribution, expression) and immune responses following administration...

Lugar: Cambridge, MA | 08/01/2025 23:01:00 PM | Salario: S/. No Especificado | Empresa: Biogen
1